Related Experiment Videos
Low-dose radiation therapy for testicular intraepithelial neoplasia
K P Dieckmann1, A Besserer, V Loy
1Department of Urology, Universitätklinikum Steglitz, Freie Universität Berlin, Federal Republic of Germany.
Abstract:
Four patients with unilateral testicular germ-cell tumor and biopsy-proven contralateral testicular intraepithelial neoplasia (TIN; so-called carcinoma in situ) received localized low-dose radiation therapy (18-20 Gy) of the testis with TIN. Repeated biopsies disclosed the disappearance of TIN and germ cells. No recurrence of TIN or germ cells was observed after a follow-up of 18-42 months. All patients reported a normal sex life without need of androgen supplementation. Serum follicle-stimulating hormone increased significantly immediately after radiation treatment and started to decline after 24 months. Serum luteinizing hormone increased slightly but not significantly. A decline after 24 months was observed in only one of three patients. Serum testosterone decreased significantly in all patients after 1 year but never became subnormal. Low-dose radiation treatment is efficacious in eradicating testicular intraepithelial neoplasia without destroying Leydig cells or stromal cells of the testis. Thus, a patient otherwise destined to develop a second testicular tumor can be spared orchiectomy and life-long hormonal replacement.
Insights
Low-dose radiation effectively treats testicular intraepithelial neoplasia (TIN), preventing secondary testicular tumors. This approach preserves testicular function and avoids orchiectomy and hormone replacement therapy.
Area of Science:
- Urologic Oncology
- Radiation Oncology
- Reproductive Endocrinology
Background:
- Testicular intraepithelial neoplasia (TIN), also known as carcinoma in situ, is a precursor to invasive testicular germ-cell tumors.
- Patients with unilateral testicular germ-cell tumors have a high risk of developing a contralateral tumor, often necessitating surveillance or treatment.
- Current management strategies for TIN may involve orchiectomy or long-term surveillance, carrying risks of infertility and hormonal imbalance.
Purpose of the Study:
- To evaluate the efficacy and safety of localized low-dose radiation therapy in eradicating testicular intraepithelial neoplasia (TIN).
- To assess the impact of low-dose radiation on Leydig cells, stromal cells, and hormonal function in patients with TIN.
- To determine if low-dose radiation can prevent the development of secondary testicular tumors and avoid the need for orchiectomy.
Main Methods:
- Four patients with unilateral testicular germ-cell tumors and biopsy-proven contralateral TIN received localized low-dose radiation therapy (18-20 Gy) to the affected testis.
- Repeated testicular biopsies were performed to assess the presence of TIN and germ cells post-treatment.
- Hormonal profiles, including serum follicle-stimulating hormone (FSH), luteinizing hormone (LH), and testosterone, were monitored throughout the follow-up period.
Main Results:
- Low-dose radiation therapy led to the complete disappearance of TIN in all treated testes, confirmed by repeated biopsies.
- No recurrence of TIN or germ cells was observed during a follow-up period of 18-42 months.
- Patients maintained normal sexual function without androgen supplementation; hormonal changes included transient FSH increase and mild, non-subnormal testosterone decrease.
Conclusions:
- Localized low-dose radiation therapy is an effective and organ-sparing treatment for testicular intraepithelial neoplasia (TIN).
- This treatment eradicates TIN without significantly impairing Leydig cell or stromal cell function, preserving hormonal balance and sexual health.
- Low-dose radiation offers a viable alternative to orchiectomy for patients at risk of developing a second testicular tumor, avoiding lifelong hormonal replacement.